Polycystic liver disease: Classification, diagnosis, treatment process, and clinical management

• 作者: Yun Huang Ze-Yu Zhang Zhi-Ming Wang
• 来源期刊: 世界肝病学杂志:英文版(电子版)
• 学科: 医学
• 关键词: POLYCYSTIC LIVER DISEASE Autosomal dominant POLYCYSTIC KIDNEY DISEASE Autosomal RECESSIVE POLYCYSTIC KIDNEY DISEASE Isolated POLYCYSTIC LIVER DISEASE DIAGNOSIS Treatment
• 年，卷（期）: 2020,（3）
• 页码范围: 72-83
• 页数: 12页
• 分类号: R73

摘要

Polycystic liver disease(PLD)is a rare hereditary disease that independently exists in isolated PLD,or as an accompanying symptom of autosomal dominant polycystic kidney disease and autosomal recessive polycystic kidney disease with complicated mechanisms.PLD currently lacks a unified diagnostic standard.The diagnosis of PLD is usually made when the number of hepatic cysts is more than 20.Gigot classification and Schnelldorfer classification are now commonly used to define severity in PLD.Most PLD patients have no clinical symptoms,and minority with severe complications need treatments.Somatostatin analogues,mammalian target of rapamycin inhibitor,ursodeoxycholic acid and vasopressin-2 receptor antagonist are the potentially effective medical therapies,while cyst aspiration and sclerosis,transcatheter arterial embolization,fenestration,hepatic resection and liver transplantation are the options of invasion therapies.However,the effectiveness of these therapies except liver transplantation are still uncertain.Furthermore,there is no unified strategy to treat PLD between medical centers at present.In order to better understand recent study progresses on PLD for clinical practice and obtain potential directions for future researches,this review mainly focuses on the recent progress in PLD classification,clinical manifestation,diagnosis and treatment.For information,we also provided medical treatment processes of PLD in our medical center.